Current Research on the Control Mechanisms of Cell Survival and Proliferation as Potential Interaction Sites with

Arkadiusz Orchel1, Jonasz Skrobek1, Anna Kaps1

  • 1Department of Biopharmacy, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice, 8 Jedności Str., 41-200 Sosnowiec, Poland.

Insights

Pentacyclic triterpenoids show promise as novel therapies for gynecological cancers, particularly ovarian cancer. These natural compounds can modulate key cellular processes and signaling pathways involved in cancer progression.

Area of Science:

  • Oncology
  • Natural Products Chemistry
  • Molecular Biology

Background:

  • Gynecological cancers often present at advanced stages, complicating treatment.
  • Chemotherapeutic resistance is a significant challenge in current cancer therapy.
  • Natural compounds like pentacyclic triterpenoids offer potential alternative therapeutic strategies.

Purpose of the Study:

  • To review the effects of pentacyclic triterpenoids on ovarian cancer cells.
  • To explore their influence on critical cellular processes and signaling pathways.

Main Methods:

  • Literature review of studies investigating pentacyclic triterpenoids in ovarian cancer.
  • Analysis of their impact on cell cycle, epithelial-mesenchymal transition, autophagy, and apoptosis.
  • Assessment of their modulation of key cancer-related signaling pathways (e.g., PI3K/AKT/mTOR, MAPK/ERK).

Main Results:

  • Pentacyclic triterpenoids exhibit diverse biological activities relevant to cancer treatment.
  • These compounds can influence cell cycle regulation, apoptosis, and epithelial-mesenchymal transition.
  • They modulate multiple signaling pathways implicated in ovarian cancer progression.

Conclusions:

  • Pentacyclic triterpenoids represent a promising class of compounds for developing novel gynecological cancer therapies.
  • Further research into their mechanisms of action and optimization is warranted.
  • Targeting specific signaling pathways with these natural compounds could overcome therapeutic resistance.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.1K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
3.8K